SCHEMBL7046971

SCHEMBL7046971

CC(CCNC(=O)C1CCN(C(=O)OC(C)(C)C)CC1)CC(=O)NCC(O)(CCc1ccccc1)c1nc2c(ccc3ccccc32)o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.39
STS P08842 1/20 0.38
USP30 Q70CQ3 1/20 0.36
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
MAPK8 P45983 1/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 2/20 0.36
THRB P10828 1/20 0.36
HTT P42858 1/20 0.35
NOD2 Q9HC29 1/20 0.35
NOD1 Q9Y239 1/20 0.35
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 2/20 0.35
NPC1 O15118 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044980 0.91 GPR119 (0.39) GPR119STSUSP30KDM4EPKM
SCHEMBL7046425 0.87 LMNA (0.39) GPR119STSUSP30KDM4EPKM
SCHEMBL6063357 0.87 CTSL (0.42) GPR119STSUSP30KDM4EPKM
SCHEMBL7049595 0.85 CTSL (0.42) GPR119STSMAPTLMNASMN1; SMN2
SCHEMBL7183817 0.81 SMN1; SMN2 (0.39) GPR119STSUSP30KDM4EPKM
SCHEMBL7049418 0.74 SMN1; SMN2 (0.40) GPR119STSUSP30KDM4EPKM
SCHEMBL22622438 0.70 ALDH1A1 (0.59) STSKDM4EPKMSMN1; SMN2GAA
SCHEMBL4922267 0.69 STS (0.65) GPR119STSKDM4EPKMGAA
SCHEMBL7046158 0.69 LMNA (0.40) GPR119STSUSP30KDM4EPKM
SCHEMBL7049421 0.69 CTSL (0.44) GPR119STSKDM4EPKMMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2003-12-18 US disclosed
US-6576630-B1 Alkanoyl substituted benzooxazoles or naphthooxazoles AXYS PHARMACEUTICALS, INC. 2003-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors SERPINB1, CTRL, CTSZ GPR119 4207/4885STS 682/4885USP30 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.